Johnson & Johnson has resumed shipping its Tylenol Cold and Flu Severe caplets, made by McNeil Consumer Healthcare, more than a year after the product was recalled due to manufacturing deficiencies.

The news comes a day after a shortage of some forms Tylenol was reported.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

McNeil Consumer Healthcare spokeswoman Bonnie Jacobs told the Wall Street Journal that the product, which is intended for adults, will be shipped this week and that the caplets were being manufactured in Italy.

Tylenol comes under a long list of products recalled by Johnson & Johnson over the last two years.

In January last year, months after first receiving consumer complaints of a musty smell, the company recalled several boxes of medicines including Benadryl, Motrin, St Joseph Aspirin and Simply Sleep.

The musty spell was suspected to be due to the contamination of the packaging with the chemical 2,4,6-tribromoanisole.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact